WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Haemonetics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-12 10:34 am Sale | 2025-06-30 | 13G | Haemonetics Corporation HAE | WELLINGTON MANAGEMENT GROUP LLP | 2,203,351 4.600% | -485,135 (-18.04%) | Filing |
| 2025-05-12 10:44 am Sale | 2025-03-31 | 13G | Haemonetics Corporation HAE | WELLINGTON MANAGEMENT GROUP LLP | 2,688,486 5.400% | -1,542,364 (-36.46%) | Filing |
| 2024-11-08 10:41 am Purchase | 2024-09-30 | 13G | Haemonetics Corporation HAE | WELLINGTON MANAGEMENT GROUP LLP | 4,230,850 8.270% | 962,767 (+29.46%) | Filing |
| 2024-02-08 10:21 am Sale | 2023-12-29 | 13G | Haemonetics Corporation HAE | WELLINGTON MANAGEMENT GROUP LLP | 3,268,083 6.440% | -766,670 (-19.00%) | Filing |
| 2023-02-06 3:00 pm Sale | 2022-12-30 | 13G | Haemonetics Corporation HAE | WELLINGTON MANAGEMENT GROUP LLP | 4,034,753 7.970% | -1,502,785 (-27.14%) | Filing |
| 2022-02-10 07:48 am Purchase | 2022-01-31 | 13G | Haemonetics Corporation HAE | WELLINGTON MANAGEMENT GROUP LLP | 5,537,538 10.830% | 447,237 (+8.79%) | Filing |
| 2022-02-04 09:27 am Purchase | 2021-12-31 | 13G | Haemonetics Corporation HAE | WELLINGTON MANAGEMENT GROUP LLP | 5,090,301 9.960% | 2,837,909 (+126.00%) | Filing |